Vanguard Health Care Index Fund Admiral Shares
FundVHCIXNASDAQ0.00 n/a
+0.00%(+0.00)
About
This economical index fund grants investors access to the American healthcare industry, including corporations involved in providing medical goods, services, cutting-edge technology, or specialized apparatus. Its principal drawback lies in its concentrated investment strategy, as it allocates capital solely to health care stocks. Therefore, significant price swings are to be expected, and it should constitute only a minor allocation within an already well-rounded investment portfolio.
Key Facts
Expense Ratio
0.09%
Assets Under Management
$19.00B
NAV
$150.91
Holdings
402
Inception Date
2004-02-05
Asset Class
Sector Equity
Issuer
Vanguard
Avg. Volume
0
Market Cap
$18.88B
Beta
0.62
52-Week Range
$119.60$150.44$151.32
52W LowCurrent52W High
Performance
1 Week
+4.18%
1 Month
+8.82%
3 Months
+10.37%
YTD
+4.52%
1 Year
+21.04%
3 Years
+23.78%
5 Years
+23.17%
Sector Exposure
- Financial Services0.03%
- Healthcare99.95%
- Industrials0.01%
- Technology0.01%
Top Holdings
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| LLY | Eli Lilly & Co | 14.01% | $2.66B |
| JNJ | Johnson & Johnson | 8.45% | $1.60B |
| ABBV | AbbVie Inc | 6.08% | $1.15B |
| UNH | UnitedHealth Group Inc | 5.45% | $1.03B |
| MRK | Merck & Co Inc | 4.63% | $880.03M |
| TMO | Thermo Fisher Scientific Inc | 2.89% | $548.73M |
| AMGN | Amgen Inc | 2.87% | $544.33M |
| GILD | Gilead Sciences Inc | 2.63% | $500.27M |
| ISRG | Intuitive Surgical Inc | 2.38% | $452.18M |
| ABT | Abbott Laboratories | 2.35% | $446.97M |
| PFE | Pfizer Inc | 2.35% | $446.49M |
| BMY | Bristol-Myers Squibb Co | 1.84% | $350.03M |
| DHR | Danaher Corp | 1.84% | $348.82M |
| CVS | CVS Health Corp | 1.83% | $347.03M |
| VRTX | Vertex Pharmaceuticals Inc | 1.80% | $341.30M |
| SYK | Stryker Corp | 1.66% | $315.28M |
| MDT | Medtronic PLC | 1.50% | $284.14M |
| MCK | McKesson Corp | 1.44% | $272.65M |
| ELV | Elevance Health Inc | 1.33% | $253.29M |
| CI | Cigna Group/The | 1.15% | $219.29M |
| BSX | Boston Scientific Corp | 1.13% | $215.26M |
| REGN | Regeneron Pharmaceuticals Inc | 1.01% | $191.52M |
| HCA | HCA Healthcare Inc | 0.94% | $177.62M |
| EW | Edwards Lifesciences Corp | 0.79% | $149.47M |
| COR | Cencora Inc | 0.79% | $149.24M |